Literature DB >> 26023548

Bronze diabetes.

Akshatha L N1, Mamatha T Shenoy1, Charu Yadav1, Rukmini M S2, Nutan Kamath3.   

Abstract

Thalassemia is a group of disorders characterized by deficient production of the β-globin sub unit of hemoglobin. The mandatory blood transfusions in patients with thalassemia to maintain adequate erythrocyte levels, leads to iron overload. The prevalence of diabetes in patients with thalassemia varies from 6 to 14%. We here by present a known case of thalassemia major in an 18 year old boy. He was diagnosed with thalassemia before the age of one year and is on regular blood transfusion every two weeks since then. The repeated blood transfusion is one of the common causes for haemochromatosis. Iron overload initially leads to glucose abnormalities such as insulin resistance and hyperinsulinemia, which is followed by impaired secretion of insulin. Diagnosed as a case of bronze diabetes, this patient is on insulin therapy for the last two years. Currently the patient is on iron chelation therapy at Kasturba Medical College Hospital, Mangalore, Karnataka, India.

Entities:  

Keywords:  Serum ferritin; Thalassemia; Type I diabetes

Year:  2015        PMID: 26023548      PMCID: PMC4437060          DOI: 10.7860/JCDR/2015/11515.5799

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  7 in total

Review 1.  Iron and diabetes risk.

Authors:  Judith A Simcox; Donald A McClain
Journal:  Cell Metab       Date:  2013-03-05       Impact factor: 27.287

Review 2.  The treatment of secondary hemochromatosis.

Authors:  Norbert Gattermann
Journal:  Dtsch Arztebl Int       Date:  2009-07-24       Impact factor: 5.594

3.  Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study.

Authors:  J Montonen; H Boeing; A Steffen; R Lehmann; A Fritsche; H-G Joost; M B Schulze; T Pischon
Journal:  Diabetologia       Date:  2012-07-01       Impact factor: 10.122

4.  The Correlation between Troponin and Ferritin Serum Levels in the Patients with Major Beta-Thalassemia.

Authors:  Iraj Shahramian; Motahhare Razzaghian; Abbas Ali Ramazani; Ghasem Ali Ahmadi; Noor Mohammad Noori; Ali Reza Rezaee
Journal:  Int Cardiovasc Res J       Date:  2013-06-01

5.  Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload.

Authors:  Robert Brudevold; Torstein Hole; Jens Hammerstrøm
Journal:  PLoS One       Date:  2008-10-28       Impact factor: 3.240

6.  Association between serum ferritin level, cardiac and hepatic T2-star MRI in patients with major β-thalassemia.

Authors:  A Eghbali; H Taherahmadi; M Shahbazi; B Bagheri; L Ebrahimi
Journal:  Iran J Ped Hematol Oncol       Date:  2014-02-20

7.  Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion.

Authors:  Monica Pinheiro de Almeida Veríssimo; Sandra Regina Loggetto; Antonio Fabron Junior; Giorgio Roberto Baldanzi; Nelson Hamerschlak; Juliano Lara Fernandes; Aderson da Silva Araujo; Clarisse Lopes de Castro Lobo; Kleber Yotsumoto Fertrin; Vasilios Antonios Berdoukas; Renzo Galanello
Journal:  Rev Bras Hematol Hemoter       Date:  2013
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.